- Antilymphocyte globulin treatment in aplastic anemia
-
Kim GW, Choi JI, Jeong BC, Lee JT, Lee KB, Whang KS
- KMID: 1698040
- Korean J Intern Med.
- 1992 Jan;42(1):43-54.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Preliminary study of antithymocyte or antilymphocyte globulin, cyclosporine-A and recombinant human granulocyte macrophage colony stimulating factors for patients with aplastic anemia
-
Kim DW, Jin JY, Lee JW, Han CW, Min WS, Kim HK, Park CW, Kim CC, Kim DJ
- KMID: 1688254
- Korean J Hematol.
- 1992 Oct;27(2):233-237.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Antilymphocyte Globulin Therapy for Aplastic Anemia in Children
-
Hong SJ, Shin HY, Ahn HS
- KMID: 2208412
- J Korean Pediatr Soc.
- 1994 Nov;37(11):1526-1539.
Immunosuppressive therapy based on the use of antilymphocyte globulin (ALG) has become standard therapy for patients with splastic anemia who are not eligible for bone marrow transplantation. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning
-
Choi M, Shin DY, Lee JY, Kim I, Yoon SS, Bang SM
- KMID: 2466598
- Blood Res.
- 2019 Dec;54(4):290-295.
- doi: 10.5045/br.2019.54.4.290
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Strategies for the Prevention of Chronic GVHD in Hematopoietic Stem Cell Transplantation
-
Lee JW
- KMID: 1485151
- Korean J Hematol.
- 2008 Mar;43(1):1-8.
- doi: 10.5045/kjh.2008.43.1.1
Chronic graft-versus-host disease (GVHD) is the most frequent late complication after hematopoietic cell transplantation and has a major impact on the quality of life and survival. As the pathophysiology of... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunomodulation Therapy in Aplastic Anemia: Relapse Rate, Complications and Long-term Survival During Follow-up for More than 1 Year
-
Lee JA, Kang HJ, Han HJ, Choi HS, Yoo ES, Shin HY, Kim JG, Ahn HS
- KMID: 2207874
- J Korean Pediatr Soc.
- 1998 Jun;41(6):775-784.
PURPOSE: We evaluated the response to immunomodulation therapy, long-term survival and relapse rate of aplastic anemia during follow-up for more than 1 year. METHODS: Twenty-eight children, with moderate to severe... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Aplastic Anemia following Hepatic Failure by Acute Hepatitis
-
Ku HJ, Lim YT, Park JH
- KMID: 2279499
- Korean J Pediatr.
- 2004 Dec;47(12):1356-1359.
Aplastic anemia following acute hepatitis or acute hepatic failure is an uncommon disease and has a poor prognosis. We experienced a case of aplastic anemia following acute hepatic failure in... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine
-
Bae SY, Han TH, Sohn BS, Oh HH, Choi SJ, Park M, Yuh YJ
- KMID: 2155943
- Korean J Med.
- 2016 Mar;90(3):258-261.
- doi: 10.3904/kjm.2016.90.3.258
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapy of severe aplastic anemia with anti-human thymocyte globulin (ATGAM) with and without HLA-haploidentical bone-marrow infusion
-
Kim KY
- KMID: 1421233
- J Korean Med Sci.
- 1986 Sep;1(1):37-41.
- doi: 10.3346/jkms.1986.1.1.37
Six patients with severe aplastic anemia treated with horse anti-human thymocyte globulin (ATG) and androgen. Four of these patients were only given ATG (ATGAMR), 16 mg/Kg/dose x 10 doses. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Allograft Immune Reaction of Kidney Transplantation Part 2. Immunosuppression and Methods to Assess Alloimmunity
-
Kang HG
- KMID: 2197196
- J Korean Soc Pediatr Nephrol.
- 2008 Oct;12(2):133-142.
For solid organ transplant, ABO blood type of donor and recipient should be compatible in principle. Recent improvement of immunosuppressant made HLA typing not so important while no-mismatch transplant still... -
- CITED
-
- Close
- SHARE
-
- Close
- Report of Two Patients with Severe Aplastic Anemia Who Showed Trilineage Hematologic Response to Low-dose Erythropoietin
-
Seo KW, Chae WS, Jeon SB, Sung WJ, Park MG, Kim JG, Sohn SK, Lee KB
- KMID: 2143321
- Korean J Hematol.
- 2002 Nov;37(4):282-286.
Aplastic anemia is characterized by multilineage bone marrow failure resulting in pancytopenia. There is no effective therapy for patients with severe aplastic anemia who were refractory to immunosuppresive therapy including... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Parvovirus B19 Related Arthropathy Associated with Antinuclear Antibody, Anti-Ro/SSA and Anti-La/SSB
-
Yoon HJ, Lee SS, Juhng HG
- KMID: 1585348
- J Korean Rheum Assoc.
- 2005 Mar;12(1):52-56.
Parvovirus B19 has been recently identified as the cause of various diseases such as erythema infectiosum, transient aplastic crisis in patients with chronic hemolytic anemias, hydrops fetalis, bone marrow suppression... -
- CITED
-
- Close
- SHARE
-
- Close
- Aplastic anemia
-
Kim HK
- KMID: 2278473
- Korean J Pediatr.
- 2007 Jun;50(6):519-523.
- doi: 10.3345/kjp.2007.50.6.519
Aplastic anemia is a rare disease, which is characterized by pancytopenia and hypocellular bone marrow without infiltration of abnormal cells or fibrosis. The incidence in Asia is higher than in... -
- CITED
-
- Close
- SHARE
-
- Close
- Aplastic Anemia
-
Kook H
- KMID: 2064968
- J Korean Med Assoc.
- 2006 Oct;49(10):885-896.
- doi: 10.5124/jkma.2006.49.10.885
Aplastic anemia (AA) is a rare hematopoietic stem-cell disorder that results in pancytopenia and hypocellular bone marrow. The pathophysiology of acquired AA is immune-mediated in most cases. Activated type 1... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
-
Ko EJ, Yu JH, Yang CW, Chung BH
- KMID: 2441017
- Korean J Intern Med.
- 2019 Mar;34(2):375-382.
- doi: 10.3904/kjim.2017.040
BACKGROUND/AIMS: Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of cytomegalovirus (CMV) infection. We aimed to evaluate the effect of valacyclovir prophylaxis against CMV... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Refractory Antibody-mediated Rejection with Bortezomib in a Kidney Transplant Recipient: A Case Report
-
Lee JY, Yoo JY, Kwon SH, Jeon JS, Noh H, Han DC, Song D, Jin SY
- KMID: 2202536
- J Korean Soc Transplant.
- 2014 Jun;28(2):87-90.
- doi: 10.4285/jkstn.2014.28.2.87
Antibody-mediated rejection (ABMR) is associated with poor renal allograft survival. It shows poor response to conventional treatment with plasmapheresis, rituximab, and intravenous immunoglobulin. Bortezomib, a proteasome inhibitor used for treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of C4d-Positive Acute Humoral Rejection Treated with Rituximab and Plasma Exchange
-
Kwon OW, Shin JH, Choi NW, Lee CH, Kim GH, Park MH, Kang CM
- KMID: 2254182
- Korean J Nephrol.
- 2006 Mar;25(2):337-341.
Although acute humoral rejection is a major cause of renal allograft loss, the diagnosis and treatment of acute humoral rejection have been very difficult because of lack of proper diagnostic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Delayed Recovery from Antibody-Mediated Rejection
-
Cho HJ, Shin EH, Yang YJ, Jung JW, Ji WJ, Choi YK, Park SK
- KMID: 2268501
- Korean J Med.
- 2014 Feb;86(2):237-241.
Antibody-mediated rejection (ABMR) in kidney transplant recipients is mediated by donor-specific antibodies. It is the major cause of graft failure in noncompliant patients and is associated with reduced long-term graft... -
- CITED
-
- Close
- SHARE
-
- Close
- Allogeneic Hematopoietic Cell Transplantation from an HLA-mismatched Family Donor: The Current Status and Future
-
Lee KH, Lee JH, Lee JH, Kim DY
- KMID: 2188060
- J Korean Med Assoc.
- 2009 Aug;52(8):819-830.
- doi: 10.5124/jkma.2009.52.8.819
Traditionally, human leukocyte antigen (HLA)-mismatched hematopoietic cell transplantation (HCT) has been considered ill-advised in a routine clinical practice due to excessive serious post-transplant complications, such as graft failure, graft-versus-host disease,... -
- CITED
-
- Close
- SHARE
-
- Close
- Fatal Invasive Pulmonary Aspergillosis after Combined Induction with Rituximab and Antithymocyte Globulin for Kidney Transplantation in a Sensitized Recipient, and Early Rejection Therapy with Plasmapheresis and Low-dose Immunoglobulin
-
Jeong DW, Lee SH, Moon JY, Kim YG, Lee YH, Kim K, Park H, Joo SH
- KMID: 2375681
- J Korean Soc Transplant.
- 2017 Mar;31(1):52-57.
- doi: 10.4285/jkstn.2017.31.1.52
A high degree of sensitization to human leukocyte antigen requires more intensive induction therapy; however, this increases vulnerability to opportunistic infections following kidney transplantation. Although recent studies have suggested that... -
- CITED
-
- Close
- SHARE
-
- Close
